{"id":39922,"date":"2020-03-28T03:00:00","date_gmt":"2020-03-28T02:00:00","guid":{"rendered":"https:\/\/www.cde.ual.es\/?p=39922"},"modified":"2020-03-27T09:49:03","modified_gmt":"2020-03-27T08:49:03","slug":"global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials","status":"publish","type":"post","link":"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/","title":{"rendered":"Global regulators map out data requirements for phase 1 COVID-19 vaccine trials"},"content":{"rendered":"<p>Global regulators have published a\u00a0<a class=\"ecl-link--external\" href=\"http:\/\/www.icmra.info\/drupal\/sites\/default\/files\/2020-03\/First%20regulatory%20COVID-19%20workshop%20-%20meeting%20report_March%202020.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">report<\/a>\u00a0presenting the outcomes of a workshop on <strong>COVID-19 vaccine development<\/strong> that was convened under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA).<\/p>\n<p><a href=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png\"><img decoding=\"async\" class=\"size-medium wp-image-16452 aligncenter\" src=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion-300x189.png\" alt=\"\" width=\"300\" height=\"189\" srcset=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion-300x189.png 300w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion-768x485.png 768w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png 927w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p>The meeting report provides an overview of regulatory considerations related to COVID-19 vaccine development and data required for regulatory decision-making on two key points:<\/p>\n<ul>\n<li>Pre-clinical data required to support proceeding to first-in-human\u00a0<a id=\"glossary-term-43092\" class=\"ecl-link glossary-term\" title=\"A study performed to investigate the safety or efficacy of a medicine. For human medicines, these studies are carried out in human volunteers.\" href=\"https:\/\/www.ema.europa.eu\/en\/glossary\/clinical-trial\" target=\"_blank\" rel=\"noopener noreferrer\">clinical trials<\/a>\u00a0with\u00a0<a id=\"glossary-term-43141\" class=\"ecl-link glossary-term\" title=\"A medicine being studied in a clinical trial.\" href=\"https:\/\/www.ema.europa.eu\/en\/glossary\/investigational-medicinal-product\" target=\"_blank\" rel=\"noopener noreferrer\">investigational medicinal products<\/a>; and<\/li>\n<li>The need to address the known theoretical risk that vaccines against COVID-19 enhance the disease prior to starting first-in-human\u00a0<a id=\"glossary-term-43092\" class=\"ecl-link glossary-term\" title=\"A study performed to investigate the safety or efficacy of a medicine. For human medicines, these studies are carried out in human volunteers.\" href=\"https:\/\/www.ema.europa.eu\/en\/glossary\/clinical-trial\" target=\"_blank\" rel=\"noopener noreferrer\">clinical trials<\/a>.<\/li>\n<\/ul>\n<p>All participants in the meeting acknowledged the urgency of conducting first-in-human\u00a0<a id=\"glossary-term-43092\" class=\"ecl-link glossary-term\" title=\"A study performed to investigate the safety or efficacy of a medicine. For human medicines, these studies are carried out in human volunteers.\" href=\"https:\/\/www.ema.europa.eu\/en\/glossary\/clinical-trial\" target=\"_blank\" rel=\"noopener noreferrer\">clinical trials<\/a>\u00a0with COVID-19 vaccine candidates. The conclusions set out how regulatory authorities around the globe intend to strike the balance between rapid development of vaccines and the need to generate enough robust data to enable decision-making.<\/p>\n<p>The meeting also aimed to encourage exchange of information about the global efforts towards developing new vaccines against COVID-19 through an open dialogue between medicines regulatory authorities around the globe.<\/p>\n<h3><strong>The workshop<\/strong><\/h3>\n<p>The regulatory workshop was held virtually on 18 March 2020 in the context of the ongoing COVID-19 pandemic. It brought together delegates from 17 different countries, representing more than 20 medicines regulatory authorities globally, as well as experts from the World Health Organization and the European Commission, to share their views on the development of vaccines against COVID-19. The meeting was co-chaired by EMA and the US Food and Drug Administration (FDA).<\/p>\n<h3>More information<\/h3>\n<p><a href=\"https:\/\/www.ema.europa.eu\/en\/news\/global-regulators-map-out-data-requirements-phase-1-covid-19-vaccine-trials\">European Medicines Agency<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Global regulators have published a\u00a0report\u00a0presenting the outcomes of a workshop on COVID-19 vaccine development that was convened under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA). The meeting report provides an overview of regulatory considerations related to COVID-19 vaccine development and data required for regulatory decision-making on two key points: Pre-clinical data [&hellip;]<\/p>\n","protected":false},"author":101012,"featured_media":16452,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[346],"tags":[1322,1352,700],"class_list":{"0":"post-39922","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-eu-news","8":"tag-coronavirus-en","9":"tag-covid-19","10":"tag-vaccine-en","11":"entry"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global regulators map out data requirements for phase 1 COVID-19 vaccine trials | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global regulators map out data requirements for phase 1 COVID-19 vaccine trials | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\" \/>\n<meta property=\"og:description\" content=\"Global regulators have published a\u00a0report\u00a0presenting the outcomes of a workshop on COVID-19 vaccine development that was convened under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA). The meeting report provides an overview of regulatory considerations related to COVID-19 vaccine development and data required for regulatory decision-making on two key points: Pre-clinical data [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cdeuniversidadalmeria\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-28T02:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png\" \/>\n\t<meta property=\"og:image:width\" content=\"927\" \/>\n\t<meta property=\"og:image:height\" content=\"585\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"BECACDE1\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cdeualmeria\" \/>\n<meta name=\"twitter:site\" content=\"@cdeualmeria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BECACDE1\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\\\/\"},\"author\":{\"name\":\"BECACDE1\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/person\\\/bf2f837cf3353e2161fe1087adbd728f\"},\"headline\":\"Global regulators map out data requirements for phase 1 COVID-19 vaccine trials\",\"datePublished\":\"2020-03-28T02:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\\\/\"},\"wordCount\":255,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Vacunacion.png\",\"keywords\":[\"Coronavirus\",\"covid-19\",\"vaccine\"],\"articleSection\":[\"EU News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\\\/\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\\\/\",\"name\":\"Global regulators map out data requirements for phase 1 COVID-19 vaccine trials | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Vacunacion.png\",\"datePublished\":\"2020-03-28T02:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Vacunacion.png\",\"contentUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Vacunacion.png\",\"width\":927,\"height\":585},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU News\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Global regulators map out data requirements for phase 1 COVID-19 vaccine trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#website\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/\",\"name\":\"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\",\"description\":\"Centro de Documentaci\u00f3n Europea de la Universidad de Almer\u00eda\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\"},\"alternateName\":\"CDE Almer\u00eda\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cde.ual.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\",\"name\":\"Centro de Documentaci\u00f3n Europea de Almer\u00eda\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cde-logo-3.png\",\"contentUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cde-logo-3.png\",\"width\":1400,\"height\":300,\"caption\":\"Centro de Documentaci\u00f3n Europea de Almer\u00eda\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/cdeuniversidadalmeria\\\/\",\"https:\\\/\\\/x.com\\\/cdeualmeria\",\"https:\\\/\\\/www.tiktok.com\\\/@cdealmeria\",\"https:\\\/\\\/www.instagram.com\\\/cdealmeria\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/cde-almera-812b26a9\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/person\\\/bf2f837cf3353e2161fe1087adbd728f\",\"name\":\"BECACDE1\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/16a4c1e422b5dec818ee13eab3353b19db9cfd278cc10f9b0e1188a37671d9d4?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/16a4c1e422b5dec818ee13eab3353b19db9cfd278cc10f9b0e1188a37671d9d4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/16a4c1e422b5dec818ee13eab3353b19db9cfd278cc10f9b0e1188a37671d9d4?s=96&d=mm&r=g\",\"caption\":\"BECACDE1\"},\"sameAs\":[\"http:\\\/\\\/www.cdealmeria.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global regulators map out data requirements for phase 1 COVID-19 vaccine trials | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/","og_locale":"en_US","og_type":"article","og_title":"Global regulators map out data requirements for phase 1 COVID-19 vaccine trials | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","og_description":"Global regulators have published a\u00a0report\u00a0presenting the outcomes of a workshop on COVID-19 vaccine development that was convened under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA). The meeting report provides an overview of regulatory considerations related to COVID-19 vaccine development and data required for regulatory decision-making on two key points: Pre-clinical data [&hellip;]","og_url":"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/","og_site_name":"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","article_publisher":"https:\/\/www.facebook.com\/cdeuniversidadalmeria\/","article_published_time":"2020-03-28T02:00:00+00:00","og_image":[{"width":927,"height":585,"url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","type":"image\/png"}],"author":"BECACDE1","twitter_card":"summary_large_image","twitter_creator":"@cdeualmeria","twitter_site":"@cdeualmeria","twitter_misc":{"Written by":"BECACDE1","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/#article","isPartOf":{"@id":"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/"},"author":{"name":"BECACDE1","@id":"https:\/\/www.cde.ual.es\/#\/schema\/person\/bf2f837cf3353e2161fe1087adbd728f"},"headline":"Global regulators map out data requirements for phase 1 COVID-19 vaccine trials","datePublished":"2020-03-28T02:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/"},"wordCount":255,"commentCount":0,"publisher":{"@id":"https:\/\/www.cde.ual.es\/#organization"},"image":{"@id":"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","keywords":["Coronavirus","covid-19","vaccine"],"articleSection":["EU News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/","url":"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/","name":"Global regulators map out data requirements for phase 1 COVID-19 vaccine trials | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","isPartOf":{"@id":"https:\/\/www.cde.ual.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/#primaryimage"},"image":{"@id":"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","datePublished":"2020-03-28T02:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/#primaryimage","url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","contentUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","width":927,"height":585},{"@type":"BreadcrumbList","@id":"https:\/\/www.cde.ual.es\/en\/global-regulators-map-out-data-requirements-for-phase-1-covid-19-vaccine-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.cde.ual.es\/en\/"},{"@type":"ListItem","position":2,"name":"EU News","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/"},{"@type":"ListItem","position":3,"name":"Global regulators map out data requirements for phase 1 COVID-19 vaccine trials"}]},{"@type":"WebSite","@id":"https:\/\/www.cde.ual.es\/#website","url":"https:\/\/www.cde.ual.es\/","name":"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","description":"Centro de Documentaci\u00f3n Europea de la Universidad de Almer\u00eda","publisher":{"@id":"https:\/\/www.cde.ual.es\/#organization"},"alternateName":"CDE Almer\u00eda","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cde.ual.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.cde.ual.es\/#organization","name":"Centro de Documentaci\u00f3n Europea de Almer\u00eda","url":"https:\/\/www.cde.ual.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cde.ual.es\/#\/schema\/logo\/image\/","url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2025\/07\/cde-logo-3.png","contentUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2025\/07\/cde-logo-3.png","width":1400,"height":300,"caption":"Centro de Documentaci\u00f3n Europea de Almer\u00eda"},"image":{"@id":"https:\/\/www.cde.ual.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cdeuniversidadalmeria\/","https:\/\/x.com\/cdeualmeria","https:\/\/www.tiktok.com\/@cdealmeria","https:\/\/www.instagram.com\/cdealmeria\/","https:\/\/www.linkedin.com\/in\/cde-almera-812b26a9\/"]},{"@type":"Person","@id":"https:\/\/www.cde.ual.es\/#\/schema\/person\/bf2f837cf3353e2161fe1087adbd728f","name":"BECACDE1","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/16a4c1e422b5dec818ee13eab3353b19db9cfd278cc10f9b0e1188a37671d9d4?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/16a4c1e422b5dec818ee13eab3353b19db9cfd278cc10f9b0e1188a37671d9d4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/16a4c1e422b5dec818ee13eab3353b19db9cfd278cc10f9b0e1188a37671d9d4?s=96&d=mm&r=g","caption":"BECACDE1"},"sameAs":["http:\/\/www.cdealmeria.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts\/39922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/users\/101012"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/comments?post=39922"}],"version-history":[{"count":0,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts\/39922\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/media\/16452"}],"wp:attachment":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/media?parent=39922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/categories?post=39922"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/tags?post=39922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}